Delivery Order SPE2DR25D3501-SPE2DR26FM0LL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,226.75 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Methylphenidate ER(LA) 40mg in quantities of 100 capsules. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures, with an ultimate completion date of November 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, valued at $3,375.52 and scheduled for completion by June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules in a quantity of 100 units, with a ceiling value of $1,020.66. This is a firm fixed price delivery order with an ultimate completion date of October 23, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,846.82 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 20mg capsules (100-count package). This competitive award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,514.42 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count packaging). This firm fixed-price delivery order, which is not set-aside, is set to be completed by November 14, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules. This is a firm fixed-price delivery order with a ceiling value of $2,359.18 and an ultimate completion date of October 23, 2025. The contract was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,987.51 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,172.12 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 40mg capsules (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation. The order was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $8,036.49 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) on October 22, 2025, with an ultimate completion date of October 23, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Methylphenidate ER tablets in 36-milligram dosage. This is a firm fixed-price delivery order with a ceiling value of $3,312.60 and an ultimate completion date of December 8, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM0LLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Methylphenidate ER(LA) 40mg capsules (100 count) with a ceiling value of $1,688.65. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The methylphenidate order represents a continuation of the company's role as a pharmaceutical prime vendor for the Defense Health Agency and other federal healthcare customers, delivering medications across multiple therapeutic domains to support military medical readiness and operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/10/25 |